Header cover image
  • Investing Ideas
  • Finnish Pharmaceuticals & Biotech Healthy potentially undervalued

Finnish Pharmaceuticals & Biotech Healthy potentially undervalued

Results

1

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Orion Oyj

Market Cap: €9.5b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€67.35

7D

-1.5%

1Y

5.7%